日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment outcome of NSCLC patients with BRAF(non-V600E) mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany

德国国家基因组医学网络(nNGM)肺癌项目中,BRAF(非V600E)突变型非小细胞肺癌患者的治疗结果:一项回顾性多中心分析

Kropf-Sanchen, C; Rasokat, A; Christopoulos, P; Wenzel, C; Wehler, T; Rost, M; Kulhavy, J; Reinmuth, N; Schulz, C; Scheffler, M; Wolf, J; Büttner, R; Merkelbach-Bruse, S; Thomas, M; Stenzinger, A; Schütz, M; Bräuninger, A; Demes, M; Hummel, H-D; Pfarr, N; Gaisa, N T; Rawluk, J; Berezucki, E; Lutz, K T; Galda, S; Jacobi, H; Collienne, M; Janning, M; Brummer, T; Loges, S

Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.

肝细胞癌的扩散是通过趋化因子受体CXCR4介导的

Schimanski C C, Bahre R, Gockel I, Müller A, Frerichs K, Hörner V, Teufel A, Simiantonaki N, Biesterfeld S, Wehler T, Schuler M, Achenbach T, Junginger T, Galle P R, Moehler M